Summary

Global Human Organoids Market was valued at USD 510.24 Million in 2024 and is expected to reach USD 643.79 Million by 2030 with a CAGR of 4.15% during the forecast period. The global human organoids market is witnessing significant growth, driven by advancements in biotechnology, increasing demand for personalized medicine, and a rise in research activities focusing on disease modeling and drug discovery. Organoids, which are three-dimensional, miniature versions of human organs grown from stem cells, offer an innovative platform for studying human biology in a more precise and ethically sustainable way compared to traditional methods. This market is gaining traction across pharmaceutical, biotechnology, and academic sectors, offering promising avenues for research, drug testing, and regenerative medicine.
Key Market Drivers
Growth in Healthcare Industry
The growth of the global healthcare industry is a key driver of the human organoids market, propelling advancements in research, personalized medicine, and drug development. The healthcare industry ranks among the largest and most rapidly expanding sectors globally. In many developed countries, healthcare expenditures exceed 10 percent of the gross domestic product (GDP), representing a substantial portion of their economies. In the United States, healthcare spending increased by 2.7 percent in 2021, totaling USD 4.3 trillion, or USD 12,914 per capita. Healthcare spending also accounted for 18.3 percent of the nation's GDP. As healthcare systems worldwide continue to expand and evolve, there is a growing emphasis on innovative solutions to enhance the understanding of human biology, improve disease modeling, and accelerate the development of novel therapeutics. Human organoids—3D structures grown from stem cells that mimic the architecture and functionality of human organs—are becoming a critical tool in these advancements.
Key Market Challenges
High Costs of Development and Research
One of the key challenges facing the global human organoids market is the high costs associated with the development and research of these advanced biological models. The process of creating organoids, which involves cultivating stem cells to mimic the structure and function of human organs, requires cutting-edge technology, specialized expertise, and extensive laboratory resources. These factors contribute to significant upfront investment and ongoing operational expenses, which can hinder the widespread adoption and scalability of organoid technology.
The development of human organoids requires sophisticated equipment such as bioreactors, 3D cell culture systems, and precise imaging technologies, all of which are expensive to acquire and maintain. In addition, the cultivation of high-quality stem cells and the optimization of growth conditions to produce functional organoids are complex tasks that demand highly skilled personnel. Hiring and training researchers with the expertise to work with these intricate models further adds to the cost burden.
Key Market Trends
Rising Applications in Drug Discovery and Testing
The rising applications of human organoids in drug discovery and testing are emerging as a significant trend in the global human organoids market, transforming the way pharmaceutical research is conducted. Human organoids, which are lab-grown 3D structures that mimic the physiological and functional properties of human organs, offer a highly accurate platform for studying human diseases, testing new drugs, and predicting treatment outcomes. This innovative technology is gaining widespread adoption in the pharmaceutical industry, driven by the need for more efficient, cost-effective, and reliable drug development processes. In 2020, 53 new medicines were introduced, and over 9,000 compounds are currently in various stages of development worldwide. The research-driven biopharmaceutical sector is estimated to have invested USD 198 billion globally in R&D during that year.
Key Market Players
• American Type Culture Collection (ATCC)
• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Canada Inc.
• Merck KGaA
• Corning Incorporated
• Bio-Techne Corporation
• ACROBIOSYSTEMS INC.
• AMS Biotechnology (Europe) Ltd
• Qkine Ltd.
• PRIMACYT Cell Culture Technology GmbH
Report Scope
In this report, the Global Human Organoids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Human Organoids Market, By Source:
o Adult Stem Cells
o Induced Pluripotent Stem Cells
o Embryonic Stem Cells
o Others
• Human Organoids Market, By Organ Type:
o Stomach Models
o Intestine Models
o Liver Models
o Pancreatic Models
o Lung Models
o Brain Models
o Kidney Models
o Others
• Human Organoids Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Human Organoids Market.
Available Customizations:
Global Human Organoids Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Human Organoids Market
5. Global Human Organoids Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others)
5.2.2. By Organ Type (Stomach Models, Intestine Models, Liver Models, Pancreatic Models, Lung Models, Brain Models, Kidney Models, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Human Organoids Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Source
6.2.2. By Organ Type
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Human Organoids Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Source
6.3.1.2.2. By Organ Type
6.3.2. Mexico Human Organoids Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Source
6.3.2.2.2. By Organ Type
6.3.3. Canada Human Organoids Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Source
6.3.3.2.2. By Organ Type
7. Europe Human Organoids Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Source
7.2.2. By Organ Type
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Human Organoids Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Source
7.3.1.2.2. By Organ Type
7.3.2. Germany Human Organoids Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Source
7.3.2.2.2. By Organ Type
7.3.3. United Kingdom Human Organoids Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Source
7.3.3.2.2. By Organ Type
7.3.4. Italy Human Organoids Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Source
7.3.4.2.2. By Organ Type
7.3.5. Spain Human Organoids Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Source
7.3.5.2.2. By Organ Type
8. Asia Pacific Human Organoids Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Source
8.2.2. By Organ Type
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Human Organoids Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Source
8.3.1.2.2. By Organ Type
8.3.2. India Human Organoids Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Source
8.3.2.2.2. By Organ Type
8.3.3. South Korea Human Organoids Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Source
8.3.3.2.2. By Organ Type
8.3.4. Japan Human Organoids Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Source
8.3.4.2.2. By Organ Type
8.3.5. Australia Human Organoids Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Source
8.3.5.2.2. By Organ Type
9. South America Human Organoids Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Source
9.2.2. By Organ Type
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Human Organoids Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Source
9.3.1.2.2. By Organ Type
9.3.2. Argentina Human Organoids Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Source
9.3.2.2.2. By Organ Type
9.3.3. Colombia Human Organoids Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Source
9.3.3.2.2. By Organ Type
10. Middle East and Africa Human Organoids Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Source
10.2.2. By Organ Type
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Human Organoids Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Source
10.3.1.2.2. By Organ Type
10.3.2. Saudi Arabia Human Organoids Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Source
10.3.2.2.2. By Organ Type
10.3.3. UAE Human Organoids Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Source
10.3.3.2.2. By Organ Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Human Organoids Market: SWOT Analysis
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1.1. American Type Culture Collection (ATCC)
15.1.2. Business Overview
15.1.3. Company Snapshot
15.1.4. Products & Services
15.1.5. Financials (As Reported)
15.1.6. Recent Developments
15.1.7. Key Personnel Details
15.1.8. SWOT Analysis
15.2. Thermo Fisher Scientific Inc.
15.3. STEMCELL Technologies Canada Inc.
15.4. Merck KGaA
15.5. Corning Incorporated
15.6. Bio-Techne Corporation
15.7. ACROBIOSYSTEMS INC.
15.8. AMS Biotechnology (Europe) Ltd
15.9. Qkine Ltd.
15.10. PRIMACYT Cell Culture Technology GmbH
16. Strategic Recommendations
17. About Us & Disclaimer